Compound of formula (I) in which R1, R2 and R3 are defined in the following description, and the pharmaceutically acceptable acid-addition or base-addition salts thereof. The invention also relates to a process and an intermediate for preparing it, and to a pharmaceutical composition comprising it. The invention also relates to the use of a novel 2H-pyrrolo[3,4-c]quinoline compound for preparing a pharmaceutical composition that is active in the treatment of disturbances of the serotoninergic system.
公式(I)的复合物,其中R1、R2和R3的定义如下所述,并且其药学上可接受的酸加成物或碱加成物盐。本发明还涉及一种制备它的过程和中间体,以及包含它的制药组合物。本发明还涉及使用一种新的
2H-吡咯并[3,4-c]
喹啉化合物制备具有治疗5-羟
色胺系统紊乱活性的制药组合物。